Results 21 to 30 of about 859,972 (336)

PROSPECTS FOR THE USE OF BIOMARKERS (ADIPONECTIN, P-SELECTIN, INTEGRIN Ββ3) AS BIOCHEMICAL PREDICTORS OF RESTENOSIS IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER CORONARY STENTING

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2018
Aim.To analyze the literature data about the role of adiponectin, P-selectin and integrin β3 in the pathogenesis of the development of in-stent restenosis in patients with coronary heart disease after coronary stenting, as well as the possibility of ...
Chernyak A. A., Snezhitskiy V. A.
doaj   +1 more source

Assessment of the role of IL6 and IL10 gene polymorphisms as a risk factor for the development of restenosis in patients after implantation of drug-eluting stents

RUDN Journal of Medicine, 2021
Relevance. Currently, the number of percutaneous coronary interventions continues to increase, which leads to an increase in the absolute number of restenosis cases, which is the main complication of the long-term postoperative period.
K. B. Timizheva, A. V. Aghajanyan, L. V. Tskhovrebova, Z. Kh. Shugushev, M. M. Azova   +4 more
doaj   +1 more source

Design and testing of hydrophobic core/hydrophilic shell nano/micro particles for drug-eluting stent coating [PDF]

, 2018
In this study, we designed a novel drug-eluting coating for vascular implants consisting of a core coating of the anti-proliferative drug docetaxel (DTX) and a shell coating of the platelet glycoprotein IIb/IIIa receptor monoclonal antibody SZ-21.
A Arsiwala, A Bierhalz, A Tan, AW Heldman, B Almería, B O’brien, B O’Brien, C Stettler, CJ Pan, CJ Sweeney, CL Song, D Sun, DM Saylor, E Boersma, E Camenzind, ES Park, ES Thian, F Danhier, GY An, H Zhang, HG Wang, J Kanzer, J Riegger, J Yang, J Zhang, JB Slee, JJ Wykrzykowska, JM Lee, JV Natarajan, K Kolandaivelu, KH Bønaa, KS Lim, M Gawaz, M Zamani, M Zamani, MK Dong, MP Skinner, MT Ali, PS Douglas, PW Erruys, RH Müller, RK Aggarwal, RL Wilensky, S Freiberg, S Garg, S Hossfeld, S Jang, S Lee, S Mcginty, S Meng, S Puricel, S Yasuda, SJ Liu, T Inoue, T Nakano, TM Ko, U Baber, X Ma, X Wu, X Xi, Y Cao, YH Lee, Z Yang   +62 more
core   +1 more source

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)

Pakistan Armed Forces Medical Journal, 2020
Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study.
Waseem Raja, Naseer Ahmed Samore, Mohsin Saif, Javeria Kamran, Sidra Waheed, Naeem Tariq, Farhan Tuyyab, Abdul Hameed Siddiqui   +7 more
doaj   +1 more source

A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]

, 2016
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L., Kennedy, Simon, McCormick, Christopher, Mullen, Alexander B., Wadsworth, Roger M.   +4 more
core   +2 more sources

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents

Российский кардиологический журнал, 2019
Aim. To identify the effect of preprocedural laboratory parameters on the occurrence of in-stent restenosis in various types of stents, to assess the significance of gender, age and various forms of coronary artery disease (CAD) as risk factors for ...
D. V. Shames, A. S. Galyavich, Z. M. Galeeva, L. V. Baleeva   +3 more
doaj   +1 more source

Layer-by-layer biofabrication of coronary covered stents with clickable elastin-like recombinamers [PDF]

, 2019
Producción CientíficaCoronary artery disease is the leading cause of death around the world. Endovascular stenting is the preferred treatment option to restore blood flow in the coronary arteries due to the lower perioperative morbidity when compared ...
Fernández Colino, Alicia, Jockenhoevel, Stefan, Mela, Petra, Moreira, Ricardo, Rodríguez Cabello, José Carlos, Rütten, Stephan, Schmitz-Rode, Thomas, Wolf, Frederic   +7 more
core   +2 more sources

Results of Coronary Stenting for Restenosis

Journal of the American College of Cardiology, 1996
This study attempted to analyze immediate and long-term angiographic and clinical results of coronary stent implantation for restenosis in a consecutive group of patients.The rate of stent utilization in patients with coronary artery disease has increased exponentially in recent years.
Akira Itoh, Massimo Ferraro, Antonio Colombo, Simonetta Blengino, Giovanni Martini, Leo Finci   +5 more
openaire   +3 more sources

A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients

Frontiers in Cardiovascular Medicine, 2022
PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng, Ying Zhao, Haiyan Wang, Jiayu Zhao, Xun Wang, Jianping Shi   +5 more
doaj   +1 more source

Reducing in-stent restenosis therapeutic manipulation of miRNA in vascular remodeling and inflammation [PDF]

, 2015
Background: Drug-eluting stents reduce the incidence of in-stent restenosis, but they result in delayed arterial healing and are associated with a chronic inflammatory response and hypersensitivity reactions. Identifying novel interventions to enhance
Baker, Andrew H., Channon, Keith M., Dakin, Rachel S., Diver, Louise A., Douglas, Gillian, Halliday, Crawford A., Kennedy, Simon, McBride, Martin W., McClure, John D., McDonald, Robert A., Miller, Ashley M., Montgomery, Jennifer, Oldroyd, Keith, Robertson, Keith E.   +13 more
core   +1 more source